Values as of: 2024-10-30
COMMON STOCK | Medical Devices |
Last Closing
USD 37.5Change
0.00 (0.00)%Market Cap
USD 8.72BVolume
N/AAnalyst Target
N/AVerdict
Verdict
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Company Website : https://www.demant.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| SEMHF | Siemens Healthineers AG |
N/A |
USD 63.76B |
| SMMNY | Siemens Healthineers AG ADR |
-0.42 (-1.58%) |
USD 62.17B |
| RYLPF | Koninklijke Philips N.V |
N/A |
USD 29.83B |
| SONVF | Sonova Holding AG |
N/A |
USD 22.04B |
| SNWV | SANUWAVE Health Inc |
-1.50 (-7.89%) |
USD 20.67B |
| SNNUF | Smith & Nephew plc |
+0.01 (+0.03%) |
USD 12.78B |
| GNGBF | Getinge AB |
N/A |
USD 5.12B |
| AMBFF | Ambu A/S |
N/A |
USD 4.94B |
| AMBBY | Ambu A/S |
N/A |
USD 4.94B |
| GGNDF | GN Store Nord A/S |
N/A |
USD 3.10B |
N/A
| Market Performance vs. Industry/Classification (Medical Devices) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -14.77% | 49% | F | 38% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -14.77% | 49% | F | 39% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -3.67% | 52% | F | 45% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -3.67% | 52% | F | 45% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 46.48% | 79% | B- | 76% | C+ | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 46.48% | 79% | B- | 76% | C+ | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 20.20% | 68% | D+ | 64% | D | ||
| Dividend Return | 20.20% | 68% | D+ | 61% | D- | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 44.82% | 69% | C- | 55% | F | ||
| Risk Adjusted Return | 45.06% | 94% | A | 81% | B- | ||
| Market Capitalization | 8.72B | 94% | A | 90% | A- | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
